Alkermes (ALKS) Income from Discontinued Operations (2023 - 2024)
Alkermes' (ALKS) quarterly Income from Discontinued Operations came in at $1.1 million in Q4 2024, up 102.74% year-over-year from $552428.6 in Q1 2024, and up 332.85% quarter-over-quarter from -$481000.0 in Q3 2024.
Powered by 
Analysis
Alkermes (ALKS) Income from Discontinued Operations (2023 - 2024) Analysis & Trends
Alkermes (ALKS) has reported Income from Discontinued Operations for 2 consecutive years, with $1.1 million the latest figure, recorded in Q4 2024.
- On a quarterly basis, Income from Discontinued Operations rose 102.74% year-over-year to $1.1 million in Q4 2024; TTM through Sep 2025 was $1.1 million, a 102.34% increase from a year earlier, with the FY2024 full-year figure at -$5.8 million, up 96.49% from the prior year.
- Income from Discontinued Operations was $1.1 million for Q4 2024 at Alkermes, up from -$481000.0 in the prior quarter.
- Over five years, Income from Discontinued Operations peaked at $1.1 million in Q4 2024 and troughed at -$45.3 million in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.32 Bn | 623.56 Bn | 17.26 Bn | - |
| 2 | AbbVie | 440.60 Bn | 434.04 Bn | 12.70 Bn | - |
| 3 | Merck | 365.39 Bn | 358.25 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.22 Bn | 147.52 Bn | 10.94 Bn | 8.00 Mn |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.21 Bn | 44.21 Bn | - | - |
| 8 | Incyte | 25.34 Bn | 20.81 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.49 Bn | 18.82 Bn | 683.80 Mn | - |
| 10 | Alkermes | 7.58 Bn | 6.93 Bn | 397.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | -481,000.00 |
| Jun 30, 2024 | -3.91 Mn |
| Mar 31, 2024 | -2.52 Mn |
| Dec 31, 2023 | -40.86 Mn |
| Sep 30, 2023 | -45.35 Mn |
| Jun 30, 2023 | -42.08 Mn |
| Mar 31, 2023 | -36.52 Mn |